Retrospective cohort study of trifluridine/tipiracil (TAS-102) plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer.

Kotani, Daisuke; Kuboki, Yasutoshi; Horasawa, Satoshi; Kaneko, Asumi; Nakamura, Yoshiaki; Kawazoe, Akihito; Bando, Hideaki; Taniguchi, Hiroya; Shitara, Kohei; Kojima, Takashi; Tsuji, Akihito; Yoshino, Takayuki

Kotani, Daisuke; Kuboki, Yasutoshi; Horasawa, Satoshi; Kaneko, Asumi; Nakamura, Yoshiaki; Kawazoe, Akihito; Bando, Hideaki; Taniguchi, Hiroya; Shitara, Kohei; Kojima, Takashi; Tsuji, Akihito; Yoshino, Takayuki.

Afiliação

Kotani D; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Kuboki Y; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan. ykuboki@east.ncc.go.jp.
Horasawa S; Department of Experimental Therapeutics, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan. ykuboki@east.ncc.go.jp.
Kaneko A; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Nakamura Y; Translational Research Support Section, Translational Research Management Division, Clinical Research Support Office, National Cancer Center Hospital East, Kashiwa, Japan.
Kawazoe A; Department of Pharmacy, National Cancer Center Hospital East, Kashiwa, Japan.
Bando H; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Taniguchi H; Translational Research Support Section, Translational Research Management Division, Clinical Research Support Office, National Cancer Center Hospital East, Kashiwa, Japan.
Shitara K; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Kojima T; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Tsuji A; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
Yoshino T; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.

BMC Cancer ; 19(1): 1253, 2019 Dec 27.

Article em En | MEDLINE | ID: mdl-31881856

Assuntos

Adenocarcinoma/tratamento farmacológico; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Bevacizumab/uso terapêutico; Neoplasias Colorretais/tratamento farmacológico; Pirrolidinas/uso terapêutico; Trifluridina/uso terapêutico; Uracila/análogos & derivados; Adulto; Idoso; Idoso de 80 Anos ou mais; Intervalo Livre de Doença; Combinação de Medicamentos; Feminino; Humanos; Masculino; Pessoa de Meia-Idade; Metástase Neoplásica; Estudos Retrospectivos; Timina; Uracila/uso terapêutico; Adulto Jovem

Palavras-chave

Lonsurf; TAS-102; Trifluridine/tipiracil plus bevacizumab; mCRC

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirrolidinas / Uracila / Neoplasias Colorretais / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Trifluridina / Bevacizumab Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google